Related Experiment Video
Updated: Jul 26, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019
Sebastian E Sattui1, Zachary S Wallace2
1Division of Rheumatology and Clinical Immunology, University of Pittsburgh, BST S723, 3500 Terrace Street, Pittsburgh, PA 15261, USA.
Abstract:
The coronavirus disease 2019 (COVID-19) pandemic has led to the emergence of multiple challenges in the care of patients with systemic rheumatic diseases. Patients with vasculitis represent a group of particular concern due to existing risk factors which include a higher burden of comorbidities and specific immunosuppressive therapies used for treatment. Vaccination and the use of other risk mitigation strategies are crucial for the care of these patients. This review provides an overview of existing evidence to contribute to the understanding and specific requirements of the treatment and management of patients with vasculitis during the time of COVID-19.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Pericarditis III: Medical Management
Endocarditis III: Medical Management
Rheumatic Heart Disease III: Medical Management
Pericarditis IV: Nursing Management

